Opinion: Europe Is Sinking Biotech—Again

Scientifically groundless regulations could undercut the potential of gene-edited crops, much as they have with GMOs.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, Elena Katkova

When it comes to modern agricultural biotechnology, Europe’s caution has been slowing progress for more than two decades. It started in the 1990s, when Europe began rejecting crops modified using recombinant DNA, or DNA from other species—crops branded as genetically modified organisms (GMOs). Now it is doing the same for gene-edited crops improved using CRISPR. European scientists have objected to this new blockage, but they are not the only ones paying a price.

Using CRISPR, researchers are now working to make crop plants that have higher yields, resist disease or stress, or are tastier, more nutritious, or more convenient than conventionally bred varieties. As farmers seek to adapt to climate change, gene editing could become an even more valuable tool in agriculture—if regulators will allow it.

Decades ago, it was transgenic modification that seemed poised to help increase drought tolerance, disease resistance, and crop yields, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Robert Paarlberg

    This person does not yet have a bio.

Published In

February 2021

Restoring Reefs

New approaches could accelerate development of outplanted corals

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences